Black Rock Inc. Citius Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,726,493 shares of CTXR stock, worth $4.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,726,493

Previous 8,457,814 3.18%

Holding current value

$4.63 Million

Previous $6.43 Million 22.19%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.6 - $0.9 $161,207 - $241,811	268,679 Added 3.18%	8,726,493 $7.85 Million
Q4 2023 Feb 13, 2024	BUY	$0.65 - $0.86 $436,588 - $577,640	671,675 Added 8.63%	8,457,814 $6.43 Million
Q3 2023 Nov 13, 2023	SELL	$0.65 - $1.25 $190,499 - $366,345	-293,076 Reduced 3.63%	7,786,139 $5.29 Million
Q2 2023 Aug 11, 2023	BUY	$1.08 - $1.65 $6.2 Million - $9.47 Million	5,739,708 Added 245.34%	8,079,215 $9.7 Million
Q1 2023 May 12, 2023	BUY	$0.78 - $1.42 $3,797 - $6,912	4,868 Added 0.21%	2,339,507 $2.74 Million

Q4 2022 Feb 13, 2023	BUY	$0.79 - $1.23 $2,006 - $3,124	2,540 Added 0.11%	2,334,639 $1.84 Million
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.33 $2,127 - $20,206	-15,193 Reduced 0.65%	2,332,099 $2.82 Million
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $5.05 Million - $10.7 Million	-5,734,887 Reduced 70.96%	2,347,292 $2.16 Million
Q1 2022 May 12, 2022	SELL	$1.38 - $1.89 $63,586 - $87,085	-46,077 Reduced 0.57%	8,082,179 $14.5 Million
Q4 2021 Feb 10, 2022	SELL	$1.51 - $2.2 $44,994 - $65,555	-29,798 Reduced 0.37%	8,128,256 $12.5 Million
Q3 2021 Nov 09, 2021	BUY	$1.74 - $2.6 $58,338 - $87,172	33,528 Added 0.41%	8,158,054 $16.6 Million
Q2 2021 Aug 11, 2021	BUY	$1.51 - $4.23 $12.3 Million - $34.4 Million	8,124,526 New	8,124,526 $28.3 Million

Others Institutions Holding CTXR

# of Institutions

Shares Held

26.8M

Call Options Held

Put Options Held

View Full List

About Citius Pharmaceuticals, Inc.

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $77.4M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

More about CTXR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account